Rational drug design via intrinsically disordered protein

Yugong Cheng, Tanguy LeGall, Christopher J. Oldfield, James P. Mueller, Ya Yue J Van, Pedro Romero, Marc S. Cortese, Vladimir N. Uversky, A. Dunker

Research output: Contribution to journalArticle

170 Citations (Scopus)

Abstract

Despite substantial increases in research funding by the pharmaceutical industry, drug discovery rates seem to have reached a plateau or perhaps are even declining, suggesting the need for new strategies. Protein-protein interactions have long been thought to provide interesting drug discovery targets, but the development of small molecules that modulate such interactions has so far achieved a low success rate. In contrast to this historic trend, a few recent successes raise hopes for routinely identifying druggable protein-protein interactions. In this Opinion article, we point out the importance of coupled binding and folding for protein-protein signalling interactions generally, and from this and associated observations, we develop a new strategy for identifying protein-protein interactions that would be particularly promising targets for modulation by small molecules. This novel strategy, based on intrinsically disordered protein, has the potential to increase significantly the discovery rate for new molecule entities.

Original languageEnglish (US)
Pages (from-to)435-442
Number of pages8
JournalTrends in Biotechnology
Volume24
Issue number10
DOIs
StatePublished - Oct 2006

Fingerprint

Intrinsically Disordered Proteins
Drug Design
Proteins
Pharmaceutical Preparations
Drug Discovery
Molecules
Drug Industry
Carrier Proteins
Drug products
Modulation

ASJC Scopus subject areas

  • Bioengineering

Cite this

Cheng, Y., LeGall, T., Oldfield, C. J., Mueller, J. P., Van, Y. Y. J., Romero, P., ... Dunker, A. (2006). Rational drug design via intrinsically disordered protein. Trends in Biotechnology, 24(10), 435-442. https://doi.org/10.1016/j.tibtech.2006.07.005

Rational drug design via intrinsically disordered protein. / Cheng, Yugong; LeGall, Tanguy; Oldfield, Christopher J.; Mueller, James P.; Van, Ya Yue J; Romero, Pedro; Cortese, Marc S.; Uversky, Vladimir N.; Dunker, A.

In: Trends in Biotechnology, Vol. 24, No. 10, 10.2006, p. 435-442.

Research output: Contribution to journalArticle

Cheng, Y, LeGall, T, Oldfield, CJ, Mueller, JP, Van, YYJ, Romero, P, Cortese, MS, Uversky, VN & Dunker, A 2006, 'Rational drug design via intrinsically disordered protein', Trends in Biotechnology, vol. 24, no. 10, pp. 435-442. https://doi.org/10.1016/j.tibtech.2006.07.005
Cheng Y, LeGall T, Oldfield CJ, Mueller JP, Van YYJ, Romero P et al. Rational drug design via intrinsically disordered protein. Trends in Biotechnology. 2006 Oct;24(10):435-442. https://doi.org/10.1016/j.tibtech.2006.07.005
Cheng, Yugong ; LeGall, Tanguy ; Oldfield, Christopher J. ; Mueller, James P. ; Van, Ya Yue J ; Romero, Pedro ; Cortese, Marc S. ; Uversky, Vladimir N. ; Dunker, A. / Rational drug design via intrinsically disordered protein. In: Trends in Biotechnology. 2006 ; Vol. 24, No. 10. pp. 435-442.
@article{4735c9ee9cd44e9bb6e76f277028c993,
title = "Rational drug design via intrinsically disordered protein",
abstract = "Despite substantial increases in research funding by the pharmaceutical industry, drug discovery rates seem to have reached a plateau or perhaps are even declining, suggesting the need for new strategies. Protein-protein interactions have long been thought to provide interesting drug discovery targets, but the development of small molecules that modulate such interactions has so far achieved a low success rate. In contrast to this historic trend, a few recent successes raise hopes for routinely identifying druggable protein-protein interactions. In this Opinion article, we point out the importance of coupled binding and folding for protein-protein signalling interactions generally, and from this and associated observations, we develop a new strategy for identifying protein-protein interactions that would be particularly promising targets for modulation by small molecules. This novel strategy, based on intrinsically disordered protein, has the potential to increase significantly the discovery rate for new molecule entities.",
author = "Yugong Cheng and Tanguy LeGall and Oldfield, {Christopher J.} and Mueller, {James P.} and Van, {Ya Yue J} and Pedro Romero and Cortese, {Marc S.} and Uversky, {Vladimir N.} and A. Dunker",
year = "2006",
month = "10",
doi = "10.1016/j.tibtech.2006.07.005",
language = "English (US)",
volume = "24",
pages = "435--442",
journal = "Trends in Biotechnology",
issn = "0167-7799",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Rational drug design via intrinsically disordered protein

AU - Cheng, Yugong

AU - LeGall, Tanguy

AU - Oldfield, Christopher J.

AU - Mueller, James P.

AU - Van, Ya Yue J

AU - Romero, Pedro

AU - Cortese, Marc S.

AU - Uversky, Vladimir N.

AU - Dunker, A.

PY - 2006/10

Y1 - 2006/10

N2 - Despite substantial increases in research funding by the pharmaceutical industry, drug discovery rates seem to have reached a plateau or perhaps are even declining, suggesting the need for new strategies. Protein-protein interactions have long been thought to provide interesting drug discovery targets, but the development of small molecules that modulate such interactions has so far achieved a low success rate. In contrast to this historic trend, a few recent successes raise hopes for routinely identifying druggable protein-protein interactions. In this Opinion article, we point out the importance of coupled binding and folding for protein-protein signalling interactions generally, and from this and associated observations, we develop a new strategy for identifying protein-protein interactions that would be particularly promising targets for modulation by small molecules. This novel strategy, based on intrinsically disordered protein, has the potential to increase significantly the discovery rate for new molecule entities.

AB - Despite substantial increases in research funding by the pharmaceutical industry, drug discovery rates seem to have reached a plateau or perhaps are even declining, suggesting the need for new strategies. Protein-protein interactions have long been thought to provide interesting drug discovery targets, but the development of small molecules that modulate such interactions has so far achieved a low success rate. In contrast to this historic trend, a few recent successes raise hopes for routinely identifying druggable protein-protein interactions. In this Opinion article, we point out the importance of coupled binding and folding for protein-protein signalling interactions generally, and from this and associated observations, we develop a new strategy for identifying protein-protein interactions that would be particularly promising targets for modulation by small molecules. This novel strategy, based on intrinsically disordered protein, has the potential to increase significantly the discovery rate for new molecule entities.

UR - http://www.scopus.com/inward/record.url?scp=33748272622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748272622&partnerID=8YFLogxK

U2 - 10.1016/j.tibtech.2006.07.005

DO - 10.1016/j.tibtech.2006.07.005

M3 - Article

C2 - 16876893

AN - SCOPUS:33748272622

VL - 24

SP - 435

EP - 442

JO - Trends in Biotechnology

JF - Trends in Biotechnology

SN - 0167-7799

IS - 10

ER -